Compare LWLG & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LWLG | IART |
|---|---|---|
| Founded | 1991 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 995.4M | 1.2B |
| IPO Year | 2011 | 1996 |
| Metric | LWLG | IART |
|---|---|---|
| Price | $6.09 | $16.73 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.33 |
| AVG Volume (30 Days) | ★ 3.0M | 833.3K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $236,855.00 | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 147.74 | N/A |
| 52 Week Low | $2.35 | $8.70 |
| 52 Week High | $18.71 | $20.49 |
| Indicator | LWLG | IART |
|---|---|---|
| Relative Strength Index (RSI) | 40.12 | 42.14 |
| Support Level | $5.61 | $16.04 |
| Resistance Level | $7.92 | $18.78 |
| Average True Range (ATR) | 0.63 | 0.69 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 7.53 | 7.58 |
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.